Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep

L. Cindrick, P. Schenarts, H. Bone, L. Traber, David Herndon, D. Traber

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

After acute lung injury transvascular fluid flux increases secondary to an increased microvascular permeability to protein, and is thought to be a consequence of an inflammatory process. This manifestation has been well documented in an ovine model in which acute lung injury is induced by smoke inhalation. Kimura et. al showed that heparin nebulization would decrease lung lymph flow. GM-1892 is a low molecular weight heparin analog that has no anticoagulation properties. We hypothesized that this heparin analog would reduce transvascular fluid flux in our ovine model. Sheep (n=12)'were surgically prepared for chronic study by placement of cardiopulmonary catheters and a lung lymph fistula. After a 5 day recovery, baseline data were collected and the sheep insufflated with cotton smoke. They were then randomized into two erouos. a control eroun (3 ml lactated rineers. n-fi} and GM-1892 (2mg/kg,n=6).The solutions were delivered via an in line nebulizing system 1 hr after injury and each subsequent 4 hrs for the duration of the study (48hrs). The GM-1892 attenuated the increase in lymph flow when compared to the control group. P<0.05, vs baseline, (†) between groups. This confirmed our hypothesis. Reference: Circ Shock, 25:333,1988. Supported by NIH GM33324 and the Shriners of NA.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1996

Fingerprint

lymph flow
Heparinoids
atomization
Acute Lung Injury
Lymph
Sheep
heparin
lungs
sheep
Smoke
Lung
Heparin
smoke
Fluxes
Fluids
Catheters
Low Molecular Weight Heparin
Cotton
lymph
fistula

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Cindrick, L., Schenarts, P., Bone, H., Traber, L., Herndon, D., & Traber, D. (1996). Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep. FASEB Journal, 10(3).

Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep. / Cindrick, L.; Schenarts, P.; Bone, H.; Traber, L.; Herndon, David; Traber, D.

In: FASEB Journal, Vol. 10, No. 3, 1996.

Research output: Contribution to journalArticle

Cindrick, L, Schenarts, P, Bone, H, Traber, L, Herndon, D & Traber, D 1996, 'Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep', FASEB Journal, vol. 10, no. 3.
Cindrick, L. ; Schenarts, P. ; Bone, H. ; Traber, L. ; Herndon, David ; Traber, D. / Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep. In: FASEB Journal. 1996 ; Vol. 10, No. 3.
@article{375a613e7a3b4b8aa4f99b4868d3cde9,
title = "Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep",
abstract = "After acute lung injury transvascular fluid flux increases secondary to an increased microvascular permeability to protein, and is thought to be a consequence of an inflammatory process. This manifestation has been well documented in an ovine model in which acute lung injury is induced by smoke inhalation. Kimura et. al showed that heparin nebulization would decrease lung lymph flow. GM-1892 is a low molecular weight heparin analog that has no anticoagulation properties. We hypothesized that this heparin analog would reduce transvascular fluid flux in our ovine model. Sheep (n=12)'were surgically prepared for chronic study by placement of cardiopulmonary catheters and a lung lymph fistula. After a 5 day recovery, baseline data were collected and the sheep insufflated with cotton smoke. They were then randomized into two erouos. a control eroun (3 ml lactated rineers. n-fi} and GM-1892 (2mg/kg,n=6).The solutions were delivered via an in line nebulizing system 1 hr after injury and each subsequent 4 hrs for the duration of the study (48hrs). The GM-1892 attenuated the increase in lymph flow when compared to the control group. P<0.05, vs baseline, (†) between groups. This confirmed our hypothesis. Reference: Circ Shock, 25:333,1988. Supported by NIH GM33324 and the Shriners of NA.",
author = "L. Cindrick and P. Schenarts and H. Bone and L. Traber and David Herndon and D. Traber",
year = "1996",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Nebulization of a non-anticoagulant heparinoid (gm1892) attenuates lung lymph flow after acute lung injury in sheep

AU - Cindrick, L.

AU - Schenarts, P.

AU - Bone, H.

AU - Traber, L.

AU - Herndon, David

AU - Traber, D.

PY - 1996

Y1 - 1996

N2 - After acute lung injury transvascular fluid flux increases secondary to an increased microvascular permeability to protein, and is thought to be a consequence of an inflammatory process. This manifestation has been well documented in an ovine model in which acute lung injury is induced by smoke inhalation. Kimura et. al showed that heparin nebulization would decrease lung lymph flow. GM-1892 is a low molecular weight heparin analog that has no anticoagulation properties. We hypothesized that this heparin analog would reduce transvascular fluid flux in our ovine model. Sheep (n=12)'were surgically prepared for chronic study by placement of cardiopulmonary catheters and a lung lymph fistula. After a 5 day recovery, baseline data were collected and the sheep insufflated with cotton smoke. They were then randomized into two erouos. a control eroun (3 ml lactated rineers. n-fi} and GM-1892 (2mg/kg,n=6).The solutions were delivered via an in line nebulizing system 1 hr after injury and each subsequent 4 hrs for the duration of the study (48hrs). The GM-1892 attenuated the increase in lymph flow when compared to the control group. P<0.05, vs baseline, (†) between groups. This confirmed our hypothesis. Reference: Circ Shock, 25:333,1988. Supported by NIH GM33324 and the Shriners of NA.

AB - After acute lung injury transvascular fluid flux increases secondary to an increased microvascular permeability to protein, and is thought to be a consequence of an inflammatory process. This manifestation has been well documented in an ovine model in which acute lung injury is induced by smoke inhalation. Kimura et. al showed that heparin nebulization would decrease lung lymph flow. GM-1892 is a low molecular weight heparin analog that has no anticoagulation properties. We hypothesized that this heparin analog would reduce transvascular fluid flux in our ovine model. Sheep (n=12)'were surgically prepared for chronic study by placement of cardiopulmonary catheters and a lung lymph fistula. After a 5 day recovery, baseline data were collected and the sheep insufflated with cotton smoke. They were then randomized into two erouos. a control eroun (3 ml lactated rineers. n-fi} and GM-1892 (2mg/kg,n=6).The solutions were delivered via an in line nebulizing system 1 hr after injury and each subsequent 4 hrs for the duration of the study (48hrs). The GM-1892 attenuated the increase in lymph flow when compared to the control group. P<0.05, vs baseline, (†) between groups. This confirmed our hypothesis. Reference: Circ Shock, 25:333,1988. Supported by NIH GM33324 and the Shriners of NA.

UR - http://www.scopus.com/inward/record.url?scp=33749149020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749149020&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -